News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Release: Arzerra® Fourth Quarter And Full Year 2013 Net Sales Figures



2/5/2014 9:20:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; February 5, 2014 – Genmab A/S (OMX: GEN) announced today that the Arzerra (ofatumumab) net sales during the fourth quarter of 2013 were GBP 18.8 million (approximately DKK 168 million). This figure consists of net sales in the US of GBP 12.3 million and in the rest of the world of GBP 6.5 million. Under the terms of the collaboration with GlaxoSmithKline (GSK), Genmab expects to receive a royalty payment of approximately DKK 34 million.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES